Tested Applications
| Positive WB detected in | HeLa cells, HepG2 cells, MCF-7 cells |
| Positive IHC detected in | human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 |
| Immunohistochemistry (IHC) | IHC : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
29450-1-AP targets BRCA2 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag31064 Product name: Recombinant human BRCA2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 210-388 aa of NM_000059 Sequence: IVRNEEASETVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVV Predict reactive species |
| Full Name | breast cancer 2, early onset |
| Calculated Molecular Weight | 384 kDa |
| Observed Molecular Weight | 384 kDa |
| GenBank Accession Number | NM_000059 |
| Gene Symbol | BRCA2 |
| Gene ID (NCBI) | 675 |
| RRID | AB_2918309 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P51587 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
BRCA2, also named as FACD and FANCD1, is involved in double-strand break repair and/or homologous recombination. BRCA2 may participate in S phase checkpoint activation. Defects in BRCA2 are a cause of genetic susceptibility to breast cancer (BC) which also called susceptibility to familial breast-ovarian cancer type 2 (BROVCA2).
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for BRCA2 antibody 29450-1-AP | Download protocol |
| IHC protocol for BRCA2 antibody 29450-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
I'll search for the citation information for this antibody.BRCA2 Polyclonal antibody (29450-1-AP) — Total citations: 17.
Journals: Molecular Cell, Nucleic Acids Research, Oncogene, Cell Reports, Cancer Gene Therapy, International Journal of Molecular Sciences, American Journal of Physiology-Cell Physiology, Journal of Enzyme Inhibition and Medicinal Chemistry, Scientific Reports, PLoS ONE, Prostate, Oncology Letters, bioRxiv, Aging, International Journal of Surgery.
Research fields: DNA damage repair and homologous recombination, replication fork stability/stress responses, cancer chemosensitivity and resistance (ovarian, breast, pancreatic, prostate, NSCLC, renal cell, bladder cancer), PARP inhibitor mechanisms, and gene/prognostic modeling.
| Species | Application | Title |
|---|---|---|
Mol Cell RAD51 succinylation regulates homologous recombination and contributes to the chemosensitivity in cancer. | ||
Nucleic Acids Res CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells | ||
Oncogene KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair. | ||
Oncogene The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2 | ||
Cell Rep Ski2-like helicase ASCC3 unwinds DNA upon fork stalling to control replication stress responses. |



